These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38648487)

  • 21. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
    da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
    Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ligand binding to G protein-coupled receptors by arachidonic acid.
    Bordayo EZ; Fawcett JR; Lagalwar S; Svitak AL; Frey WH
    J Mol Neurosci; 2005; 27(2):185-94. PubMed ID: 16186629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical role of the finger loop in arrestin binding to the receptors.
    Zheng C; Tholen J; Gurevich VV
    PLoS One; 2019; 14(3):e0213792. PubMed ID: 30875392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
    Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
    J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
    Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heteromers of μ opioid and dopamine D
    Tao YM; Yu C; Wang WS; Hou YY; Xu XJ; Chi ZQ; Ding YQ; Wang YJ; Liu JG
    Br J Pharmacol; 2017 Sep; 174(17):2842-2861. PubMed ID: 28608532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization of G protein-coupled receptors and neuronal functions.
    Gainetdinov RR; Premont RT; Bohn LM; Lefkowitz RJ; Caron MG
    Annu Rev Neurosci; 2004; 27():107-44. PubMed ID: 15217328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
    Takasaki I; Suzuki T; Sasaki A; Nakao K; Hirakata M; Okano K; Tanaka T; Nagase H; Shiraki K; Nojima H; Kuraishi Y
    J Pharmacol Exp Ther; 2004 Apr; 309(1):36-41. PubMed ID: 14711930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.
    Reiner S; Ambrosio M; Hoffmann C; Lohse MJ
    J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of mu and delta opioid receptors on neurons expressing dopamine receptor D1 has no effect on reward sensitivity.
    Harda Z; Spyrka J; Jastrzębska K; Szumiec Ł; Bryksa A; Klimczak M; Polaszek M; Gołda S; Zajdel J; Misiołek K; Błasiak A; Rodriguez Parkitna J
    Neuropharmacology; 2020 Dec; 180():108307. PubMed ID: 32941853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.
    Jordan BA; Trapaidze N; Gomes I; Nivarthi R; Devi LA
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):343-8. PubMed ID: 11134510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
    Hull LC; Llorente J; Gabra BH; Smith FL; Kelly E; Bailey C; Henderson G; Dewey WL
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1127-35. PubMed ID: 20008489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOR is not enough: identification of novel mu-opioid receptor interacting proteins using traditional and modified membrane yeast two-hybrid screens.
    Petko J; Justice-Bitner S; Jin J; Wong V; Kittanakom S; Ferraro TN; Stagljar I; Levenson R
    PLoS One; 2013; 8(6):e67608. PubMed ID: 23840749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo treatment with mu and delta, but not kappa-selective opioid agonists reduces [3H]spiperone binding to the guinea-pig striatum: autoradiographic evidence.
    Brent PJ; Bunn SJ
    Brain Res; 1994 Aug; 654(2):191-9. PubMed ID: 7987668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment.
    Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
    Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of Cell-based Neurotransmitter Fluorescent Engineered Reporters (CNiFERs) for Optical Detection of Neurotransmitters In Vivo.
    Lacin E; Muller A; Fernando M; Kleinfeld D; Slesinger PA
    J Vis Exp; 2016 May; (111):. PubMed ID: 27214050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.